Hints and tips:
...Companies including GAM, the Swiss asset manager, AstraZeneca, the Anglo-Swiss drugmaker, Burberry, the fashion house, and Wells Fargo, the US bank, all suffered shareholder revolts this year....
...But will a move from the laboratory to the boardroom improve returns for shareholders?...
...Investment, Woodford Investment Management Matt Regan General Manager, AbbVie Alan Hirzel Chief Executive, Abcam Timothy J Haines Managing Partner, Abingworth Mark Algar Co-Founder & Director, AB...
...Actavis, the highly acquisitive Dublin-based drugs maker, has agreed to buy New York’s Forest Laboratories for $25bn, its biggest purchase to date....
...Last week Watson Pharmaceuticals acquired Actavis in a $5.6bn deal, positioning the combined company as the third largest generics maker by sales....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...The modern glass and metal building with its stacks of sophisticated laboratory equipment looks like the headquarters of a Californian biotechnology company, but it is in fact the new extension of the Liverpool...
International Edition